Equity Investors Iii Lpgei ... Net Worth

The estimated Net Worth of Equity Investors Iii Lpgei ... is at least $157 Milion dollars as of 27 September 2013. Equity Lpgei owns over 34,000,000 units of Rite Aid stock worth over $3,900,000 and over the last 11 years Equity sold RAD stock worth over $152,660,000.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Equity Lpgei RAD stock SEC Form 4 insiders trading

Equity has made over 1 trades of the Rite Aid stock since 2013, according to the Form 4 filled with the SEC. Most recently Equity sold 34,000,000 units of RAD stock worth $152,660,000 on 27 September 2013.

The largest trade Equity's ever made was selling 34,000,000 units of Rite Aid stock on 27 September 2013 worth over $152,660,000. On average, Equity trades about 11,333,333 units every 0 days since 2013. As of 27 September 2013 Equity still owns at least 6,000,000 units of Rite Aid stock.

You can see the complete history of Equity Lpgei stock trades at the bottom of the page.

Insiders trading at Rite Aid

Over the last 45 years, insiders at Rite Aid have traded over $704,219,544 worth of Rite Aid stock and bought 1,989,612 units worth $9,286,101 . The most active insiders traders include Coutu Group (Pjc) Inc. Jean, John M Baumer oraz Equity Investors Iii Lpgei .... On average, Rite Aid executives and independent directors trade stock every 238 days with the average trade being worth of $2,811,488. The most recent stock trade was executed by Heyward R Donigan on 22 December 2021, trading 14,350 units of RAD stock currently worth $199,896.

What does Rite Aid do?

riteaid is a company based out of 7189 henry clay blvd, liverpool, new york, united states.

Complete history of Equity Lpgei stock trades at Rite Aid

Rite Aid executives and stock owners

Rite Aid executives and other stock owners filed with the SEC include:

• Heyward Donigan,
  President, Chief Executive Officer, Director
• Heyward Rutledge Donigan B.A.,
  Pres CEO & Director
• Jocelyn Konrad,
  Executive Vice President - Pharmacy and Retail Operations
• Matthew Schroeder,
  Chief Financial Officer, Senior Vice President
• James Peters,
  Chief Operating Officer
• Jocelyn Zazyczny Konrad,
  Exec. VP & Chief Pharmacy Officer
• James Joseph Peters Jr.,
  Chief Operating Officer
• Matthew C. Schroeder,
  CFO & Exec. VP
• Justin L. Mennen,
  Exec. VP & Chief Information Officer
• Bruce Bodaken,
  Independent Chairman of the Board
• Louis Miramontes,
  Independent Director
• Arun Nayar,
  Independent Director
• Kevin Lofton,
  Independent Director
• Robert Knowling,
  Independent Director
• Marcy Syms,
  Independent Director
• Elizabeth Burr,
  Independent Director
• Katherine Quinn,
  Independent Director
• Bari Harlam,
  Independent Director
• Paul Gilbert,
  General Counsel, Company Secretary
• Brian Hoover,
  Chief Accounting Officer
• Roxanne Schwans,
  Senior Vice President - Market Access and Pharmacy Purchasing
• Angele Robinson-Gaylord,
  Senior Vice President - Store Development
• Chris Bohrer,
  Senior Vice President - Payor and Strategic Initiatives
• Trent Kruse,
  Senior Vice President of Investor Relations, Treasury
• Erik Keptner,
  Senior Vice President, Chief Marketing Officer
• Justin Mennen,
  Senior Vice President, Chief Information Officer
• Andre Persaud,
  Executive Vice President - Retail
• Susan K. Henderson,
  Chief Communications Officer & Sr. VP
• Paul D. Gilbert,
  Exec. VP, Gen. Counsel & Corp. Sec.
• Byron Purcell,
  Sr. Director of Treasury Services & Investor Relations
• Brian T. Hoover,
  Chief Accounting Officer & Sr. VP
• Michel Coutu,
  Director
• James Donald,
  Director
• Steven Bixler,
  Chief Accounting Officer
• Bryan B Everett,
  CHIEF OPERATING OFFICER
• Frank A Savage,
  Director
• Michael N Regan,
  Director
• Myrtle S Potter,
  Director
• Joseph B Jr Anderson,
  Director
• Castle Dedra Newman,
  EVP
• David Jessick,
  Director
• John T Standley,
  Senior EVP & CAO
• David Abelman,
  EVP
• Tony Montini,
  EVP
• Darren W Karst,
  EVP & CFO
• Kermit R Crawford,
  President and COO
• Jessica Kazmaier,
  EVP, Chief HR Officer
• James J Comitale,
  EVP, General Counsel, Secy.
• Matt Schroeder,
  EVP, Chief Financial Officer
• Derek S. Griffith,
  Field EVP, Store Operations
• Benjamin Bulkley,
  CEO EnvisionRXOptions
• Kenneth Martindale,
  Senior Executive VP
• Andre Belzile,
  Director
• Dennis Wood,
  Director
• Philip G Satre,
  Director
• Robert Gerald Miller,
  Director
• Pierre Legault,
  Senior EVP - CAO
• Equity Investors Iii Lpgree...,
  
• Stuart M Sloan,
  Director
• Douglas E Donley,
  Senior VP and CAO
• Colin V Reed,
  Director
• Robert Sari,
  SVP AND GENERAL COUNSEL and
• Michael A Friedman,
  Director
• Jonathan Ddanhakl John G So...,
  
• George Golleher,
  Director
• Robert J Easley,
  Chief Operating Officer
• Mary F Sammons,
  PRESIDENT & CEO
• Bruin Jerry Mark De,
  EVP, Pharmacy
• Mark C Panzer,
  SR. EVP - Store Operations
• Alfred Gleason,
  Director
• Equity Investors Iii Lpgree...,
  
• Kevin Twomey,
  SVP & CHIEF ACCOUNTING OFFICER
• Robert A Mariano,
  Director
• James P Mastrian,
  SR.EVP.- Category Management
• Christopher Hall,
  EVP and CFO
• Robert K Thompson,
  EVP
• Robert Ivan Thompson,
  EVP - Pharmacy
• Frank Vitrano,
  Chief Admin. Officer & CFO
• Marc A Strassler,
  EVP,General Counsel
• Coutu Group (Pjc) Inc. Jean,
  10% owner
• Brian Fiala,
  Executive VP, Operations
• Equity Investors Iii Lpgei ...,
  
• John M Baumer,
  Director
• Francois J Coutu,
  Director
• Dan Robson,
  President, EnvisionRXOptions
• Ray Smithberger,
  SVP, Operations